Inflammation and epilepsy in the developing brain: Clinical and experimental evidence

CNS Neuroscience and Therapeutics

Volumn 21, Issue 2, 2015, Pages 141-151

  Dupuis, Nina ^a,b,c   Auvin, Stéphane ^a,b,c  

^a INSERM   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Developing Brain; Epilepsy; Epileptogenesis; IL 1; Inflammation

Indexed keywords

ACUTE BRAIN DISEASE; AUTOIMMUNE DISEASE; AUTOIMMUNE ENCEPHALITIS; BENIGN CHILDHOOD EPILEPSY; BRAIN DEVELOPMENT; CELL DAMAGE; CLINICAL STUDY; DEVELOPMENTAL STAGE; DISEASE ASSOCIATION; ENCEPHALITIS; EPILEPSY; EPILEPTIC STATE; EPILEPTOGENESIS; EXPERIMENTAL HYPERTHERMIA; EXPERIMENTAL MODEL; FEBRILE CONVULSION; FEVER; FOCAL EPILEPSY; HUMAN; IMMUNE RESPONSE; INFLAMMATORY DISEASE; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); NONHUMAN; PARANEOPLASTIC NEUROPATHY; RASMUSSEN SYNDROME; REVIEW; SEIZURE; SEIZURE SUSCEPTIBILITY; SEVERE MYOCLONIC EPILEPSY IN INFANCY; ANIMAL; BRAIN; COMPLICATION; GROWTH, DEVELOPMENT AND AGING; MEDICAL RESEARCH; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; BIOMEDICAL RESEARCH; BRAIN; ENCEPHALITIS; EPILEPSY; HUMANS;

EID: 84921465673     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12371     Document Type: Review

References (93)

1. Rivest S. Regulation of innate immune responses in the brain. Nat Rev Immunol 2009;9:429-439.
2. Vezzani A, Friedman A, Dingledine RJ. The role of inflammation in epileptogenesis. Neuropharmacology 2013;69:16-24.
3. Vezzani A, Aronica E, Mazarati A, Pittman QJ. Epilepsy and brain inflammation. Exp Neurol 2013;244:11-21.
4. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010;51:676-685.
5. Shinnar S, Glauser TA. Febrile seizures. J Child Neurol 2002;17:S44-S52.
6. Sakai R, Nujima S, Marui E. Parental knowledge and perceptions of fever in children and fever management practices differences between parents of children with and without a history of febrile seizures. Pediatr Emerg Care 2009;25:231-237.
7. Kolahi AA, Tahmooreszadeh S. First febrile convulsions: Inquiry about the knowledge, attitudes and concerns of the patients' mothers. Eur J Pediatr 2009;168:167-171.
8. Auvin S, Vallée L. Febrile seizures: Current understanding of pathophysiological mechanisms. Arch Pediatr 2009;16:450-456.
9. Berg AT. Are febrile seizures provoked by a rapid rise in temperature. Am J Dis Child 1993;147:1101-1103.
10. Minchom PE, Wallace SJ. Febrile convulsions - electroencephalographic changes related to rectal temperature. Arch Dis Child 1984;59:371-373.
11. Millichap JG, Millichap JJ. Role of viral infections in the etiology of febrile seizures. Pediatr Neurol 2006;35:165-172.
12. Millichap JJ, Millichap JG. Methods of investigation and management of infections causing febrile seizures. Pediatr Neurol 2008;39:381-386.
13. Chung B, Wong V. Relationship between five common viruses and febrile seizure in children. Arch Dis Child 2007;92:589-593.
14. Epstein LG, Shinnar S, Hesdorffer DC, et al. Human herpesvirus 6 and 7 in febrile status epilepticus: The FEBSTAT study. Epilepsia 2012;53:1481-1488.
15. Lewis DV, Shinnar S, Hesdorffer DC, et al. Hippocampal sclerosis after febrile status epilepticus: The FEBSTAT study. Ann Neurol 2014;75:178-185.
16. Kanemoto K, Kawasaki J, Yuasa S, et al. Increased frequency of Interleukin-1 beta-511T allele in patients with temporal lobe epilepsy, hippocampal sclerosis, and prolonged febrile convulsion. Epilepsia 2003;44:796-799.
17. Kauffman MA, Moron DG, Consalvo D, Bello R, Kochen S. Association study between interleukin 1 beta gene and epileptic disorders: A HuGe review and a meta-analysis. Genet Med 2008;10:83-88.
18. Fang PC, Chen YJ, Lee IC. Seizure precipitants in children with intractable epilepsy. Brain Dev 2008;30:527-532.
19. Frucht MM, Quigg M, Schwaner C, Fountain NB. Distribution of seizure precipitants among epilepsy syndromes. Epilepsia 2000;41:1534-1539.
20. Desnous B, Goujon E, Bellavoine V, Merdariu D, Auvin S. Perceptions of fever and fever management practices in parents of children with Dravet syndrome. Epilepsy Behav 2011;21:446-448.
21. McIntosh AM, McMahon J, Dibbens LM, et al. Effects of vaccination on onset and outcome of Dravet syndrome: A retrospective study. Lancet Neurol 2010;9:592-598.
22. Verbeek NE, van der Maas NAT, Jansen FE et al. Prevalence of SCN1A-related dravet syndrome among children reported with seizures following vaccination: A population-based ten-year Cohort Study. PLoS ONE, 2013; 8:e65758.
23. Villeneuve N, Laguitton V, Viellard M, et al. Cognitive and adaptive evaluation of 21 consecutive patients with Dravet syndrome. Epilepsy Behav 2014;31:143-148.
24. Nabbout R, Chemaly N, Chipaux M et al. Encephalopathy in children with Dravet syndrome is not a pure consequence of epilepsy. Orphanet J Rare Dis 2013; 8:176.
25. Auvin S. Should we still consider Dravet syndrome an epileptic encephalopathy? Epilepsy Behav 2014;36:80-81.
26. Panayiotopoulos CP, Michael M, Sanders S, Valeta T, Koutroumanidis M. Benign childhood focal epilepsies: Assessment of established and newly recognized syndromes. Brain 2008;131:2264-2286.
27. Covanis A. Panayiotopoulos syndrome: A benign childhood autonomic epilepsy frequently imitating encephalitis, syncope, migraine, sleep disorder, or gastroenteritis. Pediatrics 2006;118:E1237-E1243.
28. Cordelli DM, Aldrovandi A, Gentile V, et al. Fever as a seizure precipitant factor in Panayiotopoulos syndrome: A clinical and genetic study. Seizure 2012;21:141-143.
29. Nabbout R, Vezzani A, Dulac O, Chiron C. Acute encephalopathy with inflammation-mediated status epilepticus. Lancet Neurol 2011;10:99-108.
30. Auvin S, Bellavoine V, Merdariu D, et al. Hemiconvulsion-hemiplegia-epilepsy syndrome: Current understandings. Eur J Paediatr Neurol 2012;16:413-421.
31. Auvin S, Devisme L, Maurage CA, et al. Neuropathological and MRI findings in an acute presentation of hemiconvulsion-hemiplegia: A report with pathophysiological implications. Seizure 2007;16:371-376.
32. Howell KB, Katanyuwong K, Mackay MT, et al. Long-term follow-up of febrile infection-related epilepsy syndrome. Epilepsia 2012;53:101-110.
33. Kramer U, Chi CS, Lin KL, et al. Febrile infection-related epilepsy syndrome (FIRES): Pathogenesis, treatment, and outcome A multicenter study on 77 children. Epilepsia 2011;52:1956-1965.
34. Getts DR, Balcar VJ, Matsumoto I, Muller M, King NJ. Viruses and the immune system: Their roles in seizure cascade development. J Neurochem 2008;104:1167-1176.
35. Misra UK, Tan CT, Kalita J. Viral encephalitis and epilepsy. Epilepsia 2008;49(Suppl 6):13-18.
36. Annegers JF, Hauser WA, Beghi E, Nicolosi A, Kurland LT. The risk of unprovoked seizures after encephalitis and meningitis. Neurology 1988;38:1407-1410.
37. Rocca WA, Sharbrough FW, Hauser WA, Annegers JF, Schoenberg BS. Risk factors for complex partial seizures: A population-based case-control study. Ann Neurol 1987;21:22-31.
38. Davison KL, Crowcroft NS, Ramsay ME, Brown DW, Andrews NJ. Viral encephalitis in England, 1989-1998: What did we miss? Emerg Infect Dis 2003;9:234-240.
39. Nicolosi A, Hauser WA, Beghi E, Kurland LT. Epidemiology of central nervous system infections in Olmsted County, Minnesota, 1950-1981. J Infect Dis 1986;154:399-408.
40. Armangue T, Petit-Pedrol M, Dalmau J. Autoimmune Encephalitis in Children. J Child Neurol 2012;27:1460-1469.
41. Mann AP, Grebenciucova E, Lukas RV. Anti-N-methyl-D-aspartate-receptor encephalitis: Diagnosis, optimal management, and challenges. Ther Clin Risk Manag 2014;10:517-525.
42. Moscato EH, Peng XY, Jain A, et al. Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol 2014;76:108-119.
43. Pardo CA, Vining EPG, Guo L, et al. The pathology of Rasmussen syndrome: Stages of cortical involvement and neuropathological studies in 45 hemispherectomies. Epilepsia 2004;45:516-526.
44. Hart YM, Andermann F, Robitaille Y, et al. Double pathology in Rasmussen's syndrome - A window on the etiology? Neurology 1998;50:731-735.
45. Takei H, Wilfong A, Malphrus A, et al. Dual pathology in Rasmussen's encephalitis: A study of seven cases and review of the literature. Neuropathology 2010;30:381-391.
46. Schwab N, Bien CG, Waschbisch A, et al. CD8 T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery. Brain 2009;132:1236-1246.
47. Varadkar S, Bien CG, Kruse CA, et al. Rasmussen's encephalitis: Clinical features, pathobiology, and treatment advances. Lancet Neurol 2014;13:195-205.
48. Blumcke I, Thom M, Aronica E, et al. The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 2011;52:158-174.
49. Boer K, Spliet WG, van Rijen PC, et al. Evidence of activated microglia in focal cortical dysplasia. J Neuroimmunol 2006;173:188-195.
50. Iyer A, Zurolo E, Spliet WG, et al. Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias. Epilepsia 2010;51:1763-1773.
51. Ravizza T, Boer K, Redeker S, et al. The IL-1beta system in epilepsy-associated malformations of cortical development. Neurobiol Dis 2006;24:128-143.
52. Zurolo E, Iyer A, Maroso M, et al. Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development. Brain 2011;134:1015-1032.
53. Choi J, Nordli DR, Alden TD et al. Cellular injury and neuroinflammation in children with chronic intractable epilepsy. J Neuroinflammation 2009;6:38.
54. Iori V, Maroso M, Rizzi M, et al. Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures. Neurobiol Dis 2013;58:102-114.
55. Maroso M, Balosso S, Ravizza T, et al. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med 2010;16:413-419.
56. Auvin S, Pineda E, Shin D, Gressens P, Mazarati A. Novel Animal Models of Pediatric Epilepsy. Neurotherapeutics 2012;9:245-261.
57. Sankar R, Shin DH, Liu HT, et al. Patterns of status epilepticus-induced neuronal injury during development and long-term consequences. J Neurosci 1998;18:8382-8393.
58. Auvin S, Shin D, Mazarati A, Sankar R. Inflammation induced by LPS enhances epileptogenesis in immature rat and may be partially reversed by IL1RA. Epilepsia 2010;51:34-38.
59. Ravizza T, Rizzi M, Perego C, et al. Inflammatory response and glia activation in developing rat hippocampus after status epilepticus. Epilepsia 2005;46(Suppl 5):113-117.
60. Rizzi M, Perego C, Aliprandi M, et al. Glia activation and cytokine increase in rat hippocampus by kainic acid-induced status epilepticus during postnatal development. Neurobiol Dis 2003;14:494-503.
61. Dube CM, Ravizza T, Hamamura M, et al. Epileptogenesis provoked by prolonged experimental febrile seizures: Mechanisms and biomarkers. J Neurosci 2010;30:7484-7494.
62. Balosso S, Maroso M, Sanchez-Alavez M, et al. A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta. Brain 2008;131:3256-3265.
63. Marcon J, Gagliardi B, Balosso S, Maroso M, Noé F, Morin M, Lerner-Natoli M, Vezzani A, Ravizza T. Age-dependent vascular changes induced by status epilepticus in rat forebrain: implications for epileptogenesis. Neurobiol Dis. 2009;34:121-132.
64. Auvin S, Shin D, Mazarati A, et al. Inflammation exacerbates seizure-induced injury in the immature brain. Epilepsia 2007;48:27-34.
65. Kaindl AM, Degos V, Peineau S, et al. Activation of microglial N-methyl-D-aspartate receptors triggers inflammation and neuronal cell death in the developing and mature brain. Ann Neurol 2012;72:536-549.
66. Baram TZ, Gerth A, Schultz L. Febrile seizures: An appropriate-aged model suitable for long-term studies. Brain Res Dev Brain Res 1997;98:265-270.
67. Bender RA, Dube C, Gonzalez-Vega R, Mina EW, Baram TZ. Mossy fiber plasticity and enhanced hippocampal excitability, without hippocampal cell loss or altered neurogenesis, in an animal model of prolonged febrile seizures. Hippocampus 2003;13:399-412.
68. Dube C, Chen K, Eghbal-Ahmadi M, et al. Prolonged febrile seizures in the immature rat model enhance hippocampal excitability long term. Ann Neurol 2000;47:336-344.
69. Dube C, Vezzani A, Behrens M, Bartfai T, Baram TZ. Interleukin-1 beta contributes to the generation of experimental febrile seizures. Ann Neurol 2005;57:152-155.
70. Heida JG, Boisse L, Pittman QJ. Lipopolysaccharide-induced febrile convulsions in the rat: Short-term sequelae. Epilepsia 2004;45:1317-1329.
71. Heida JG, Teskey GC, Pittman QJ. Febrile convulsions induced by the combination of lipopolysaccharide and low-dose kainic acid enhance seizure susceptibility, not epileptogenesis, in rats. Epilepsia 2005;46:1898-1905.
72. Heida JG, Pittman QJ. Causal links between brain cytokines and experimental febrile convulsions in the rat. Epilepsia 2005;46:1906-1913.
73. Auvin S, Porta N, Nehlig A, et al. Inflammation in rat pups subjected to short hyperthermic seizures enhances brain long-term excitability. Epilepsy Res 2009;86:124-130.
74. Sayyah M, Javad-Pour M, Ghazi-Khansari M. The bacterial endotoxin lipopolysaccharide enhances seizure susceptibility in mice: Involvement of proinflammatory factors: Nitric oxide and prostaglandins. Neuroscience 2003;122:1073-1080.
75. Kovacs Z, Dobolyi A, Juhasz G, Kekesi KA. Lipopolysaccharide induced increase in seizure activity in two animal models of absence epilepsy WAG/Rij and GAERS rats and Long Evans rats. Brain Res Bull 2014;104:7-18.
76. Abraham J, Fox PD, Condello C, Bartolini A, Koh S. Minocycline attenuates microglia activation and blocks the long-term epileptogenic effects of early-life seizures. Neurobiol Dis 2012;46:425-430.
77. Somera-Molina KC, Robin B, Somera CA, et al. Glial activation links early-life seizures and long-term neurologic dysfunction: Evidence using a small molecule inhibitor of proinflammatory cytokine upregulation. Epilepsia 2007;48:1785-1800.
78. Galic MA, Riazi K, Heida JG, et al. Postnatal inflammation increases seizure susceptibility in adult rats. J Neurosci 2008;28:6904-6913.
79. Galic MA, Riazi K, Henderson AK, Tsutsui S, Pittman QJ. Viral-like brain inflammation during development causes increased seizure susceptibility in adult rats. Neurobiol Dis 2009;36:343-351.
80. Harre EM, Galic MA, Mouihate A, Noorbakhsh F, Pittman QJ. Neonatal inflammation produces selective behavioural deficits and alters N-methyl-D-aspartate receptor subunit mRNA in the adult rat brain. Eur J Neurosci 2008;27:644-653.
81. Auvin S, Mazarati A, Shin D, Sankar R. Inflammation enhances epileptogenesis in the developing rat brain. Neurobiol Dis 2010;40:303-310.
82. Pineda E, Shin D, You SJ, et al. Maternal immune activation promotes hippocampal kindling epileptogenesis in mice. Ann Neurol 2013;74:11-19.
83. Crespel A, Coubes P, Rousset MC, et al. Inflammatory reactions in human medial temporal lobe epilepsy with hippocampal sclerosis. Brain Res 2002;952:159-169.
84. Aronica E, Boer K, van Vliet EA, et al. Complement activation in experimental and human temporal lobe epilepsy. Neurobiol Dis 2007;26:497-511.
85. Ravizza T, Gagliardi B, Noe F, et al. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: Evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 2008;29:142-160.
86. Omran A, Peng J, Zhang CL, et al. Interleukin-1 beta and microRNA-146a in an immature rat model and children with mesial temporal lobe epilepsy. Epilepsia 2012;53:1215-1224.
87. Das A, Wallace GC, Holmes C, et al. Hippocampal tissue of patients with refractory temporal lobe epilepsy is associated with astrocyte activation, inflammation, and altered expression of channels and receptors. Neuroscience 2012;220:237-246.
88. Pernhorst K, Herms S, Hoffmann P, et al. TLR4, ATF-3 and IL8 inflammation mediator expression correlates with seizure frequency in human epileptic brain tissue. Seizure 2013;22:675-678.
89. Boer K, Troost D, Jansen F, et al. Clinicopathological and immunohistochemical findings in an autopsy case of tuberous sclerosis complex. Neuropathology 2008;28:577-590.
90. Lee SH, Han SH, Lee KW. Kainic acid-induced seizures cause neuronal death in infant rats pretreated with lipopolysaccharide. NeuroReport 2000;11:507-510.
91. Lothman EW, Hatlelid JM, Zorumski CF, et al. Kindling with rapidly recurring hippocampal seizures. Brain Res 1985;360:83-91.
92. Michelson HB, Lothman EW. An ontogenic study of kindling using rapidly recurring hippocampal seizures. Dev Brain Res 1991;61:79-85.
93. Sankar R, Auvin S, Kwon YS, et al. Evaluation of development-specific targets for antiepileptogenic therapy using rapid kindling. Epilepsia 2010;51:39-42.